Jan 7, 2026
Which regulatory approvals and payer coverage decisions have most affected patient access to sacral neuromodulation in the last five years?
Over the past five years, two interlocking forces have driven patient access to sacral neuromodulation (SNM): a flurry of FDA device approvals that expanded the available implants and indications, and...